VY-201

N/A

Report date: 2022/04/07 15:22:13

Base Information

Drug NameVY-201
Drug Alias NameVY-201
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionRetinoic acid receptors modulatorsCytotoxic T lymphocytes stimulantsNatural killer cells stimulants
TargetsRetinoic acid receptors
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVycellix Inc
China Registration ClassN/A

Develop Information

Active CompaniesVycellix Inc
Inactive CompaniesN/A
Active IndicationsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A